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Opioid use disorders touch the lives of many families, and numerous factors influence the
decision to use substances. Your child’s drug use does not mean that you are unsuccessful
at parenting. As a parent, consider the following actions you can take to support your child
and family if you suspect your child is using opioids. A number of resources, both local and
national, are listed at the end of this fact sheet for further guidance and support services.

#1 - Get help.

You are not alone, and there are people who can provide assistance. It’s important to reach out
to those you trust (e.g., a religious leader, therapist, healthcare provider), as they will be able to
connect you with services. For example, a licensed mental health professional can assess your
child to help identify and treat some of the factors driving the substance use. Youth with mood
and/or anxiety disorders are at higher risk for substance use (Conway et al., 2016) and opioid
overdose (Hadland et al., 2021), so making sure your child has mental health care from trained
professionals is an essential piece to the treatment plan.

#2 - Prepare for conversations with your
child and keep communication open.

Every parent-child relationship is different and will
affect how you choose to start a conversation.
Consider using the suggested resources,
which provide advice on setting
boundaries, using positive
reinforcement to encourage
behavior change, and allowing
your child to experience
consequences.

#3 - Get trained on how to use naloxone (Narcan®).

Overdose due to opioids remains the leading cause of death in Utah (Utah Department of Health,
n.d.). Naloxone (Narcan®) is a medication used to temporarily reverse an opioid overdose.
It is safe, effective, and saves lives. According to the Utah Department of Health (n.d.), almost
anyone can learn the signs of opioid overdose and how to use a naloxone (Narcan®) rescue kit.
Access naloxone kits at public libraries, police departments, and health departments. Trainings on
administering naloxone are available in your community and many online videos
(see links on page 3).
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#4 - Talk to your child and a doctor
about treatment.
Not all health information about your child can be shared because the Health Insurance
Portability and Accountability Act of 1996 (HIPAA) confidentiality rules may apply. Team up
with your child and a healthcare provider (such as your primary care doctor) to choose a
treatment and recovery path. Treatment can include medications for opioid use disorder
(MOUD) and individual and family therapy. Buprenorphine (sometimes called by the brand
name “Suboxone®”) is an effective medication used to treat opioid use disorders and is
approved by the U.S. Food and Drug Administration for youth aged 16 and older. The American
Academy of Pediatrics recommends youth with opioid use disorders have access to MOUD
like buprenorphine. According to the Committee on Substance Use and Prevention (2016),
research shows using this medication for long-term treatment (more than eight weeks) helps
retain young patients in treatment and reduces risky opioid use.

Resources

Starting a Conversation With Doctors
Use Only as Directed: https://useonlyasdirected.org/
Finding Doctors and Other Providers Who Prescribe Buprenorphine
Substance Abuse and Mental Health Services Administration (SAMHSA) buprenorphine practitioner
locator: https://www.samhsa.gov/medication-assisted-treatment/practitioner-program-data/
treatment-practitioner-locator
Training on Naloxone
Utah Naloxone: http://www.utahnaloxone.org
Utah.gov: https://naloxone.utah.gov/public
Utah State University naloxone training:
https://healthequity.usu.edu/troi-resource-center
Educating Yourself
Utah Coalition for Opioid Overdose Prevention:
https://ucoop.utah.gov/
Stop the Opidemic: https://www.opidemic.org/
Utah.gov: https://naloxone.utah.gov/resources

How to Use
Naloxone

(American Medical Association)

https://www.youtube.com/
watch?v=-xTKsHFBXlI
Photo Credit: Stop the Opidemic (opidemic.org),
Utah Department of Health. Used with permission.

Accessing Support Services
Utah Crisis Line: 1-800-273-TALK (8255) – free and confidential
SAMHSA’s National Helpline: 1-800-662-HELP (4357) – free and confidential, 24/7, 365 days-a-year
treatment referral and information service (in English and Spanish) for individuals and families facing
mental and/or substance use disorders.
Partnership to End Addiction: https://drugfree.org/about-us/
Parents Empowered: https://parentsempowered.org/
Talk. They Hear You: https://www.samhsa.gov/talk-they-hear-you
Stop the Opidemic: https://www.opidemic.org/
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